[ACIDUM NALIDIXICUM--A NEW CHEMOTHERAPEUTIC AGENT].
D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D009287:Naphthyridines; D011552:Pseudomonas Infections; D011550:Pseudomonas aeruginosa; D012106:Research; D013203:Staphylococcal Infections; D013210:Staphylococcus; D013290:Streptococcal Infections; D013291:Streptococcus; D014552:Urinary Tract Infections; D014556:Urine
D009287:Naphthyridines
DRUG RESISTANCE, MICROBIAL; EXPERIMENTAL LAB STUDY; NAPHTHYRIDINES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; URINARY TRACT INFECTIONS; URINE
ACIDUM NALIDIXICUM--ET NYTT KJEMOTERAPEUTICUM. UNDERSOKELSE IN VITRO AV RESISTENSFORHOLD VED URINVEISINFEKSJONER.